1060 Capital’s Chemours CC Stock Holding History

1060 Capital’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-251,177	Closed	-$9.53M	–	36
2017 Q2	$9.53M	Buy	+251,177	New	+$9.91M	2.18%	20

Other funds holding CC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

1060 Capital's CC Position: Q3 2017 in Review

1060 Capital sold out of Chemours (CC) in Q3 2017, closing a stake of 251,177 shares — an estimated $9.53M sold.

1060 Capital first reported a position in CC in Q2 2017 and held it in 1 quarter. The position peaked at $9.53M in Q2 2017. 499 funds tracked by Wall St. Rank hold CC as of Q3 2017.

1060 Capital reported no remaining Chemours position as of Q3 2017 after selling out during the quarter.
1060 Capital sold 251,177 Chemours shares in Q3 2017, an estimated $9.53M.
1060 Capital first reported a position in Chemours in Q2 2017 and held it in 1 quarter.
1060 Capital's Chemours position peaked at $9.53M in Q2 2017.
499 funds tracked by Wall St. Rank held Chemours as of Q3 2017.

Based on 1060 Capital's 13F filing for Q3 2017, filed 8 Nov 2017.